Here's what to expect this week on Diagnostic Imaging.
In this week’s preview, here are some highlights of what you can expect to see coming soon on Diagnostic Imaging:
In continuing end-of-year coverage, keep an eye out for a look back at CT throughout 2020. What were the biggest developments and changes during the year. The biggest focus over the past nine months has certainly been with COVID-19, but what else happened with the modality as the pandemic raged?
For additional end-of-year coverage, click here.
For more coverage based on industry expert insights and research, subscribe to the Diagnostic Imaging e-Newsletter here.
RadXX announced their four award winners during RSNA – Trailblazer, Advocate, Rising Star, and Champion. Diagnostic Imaging spoke with each winner to find out not only what launched their interest in medical imaging informatics, but also what their visions were for the specialty going forward. Later this week, you can access a short video where they share their thoughts in their own words.
For more of the RadXX profiles, click here.
In the past 40 years, liver cancer diagnoses have tripled, and deaths have nearly doubled, making it a cancer to watch closely. Later this week, look for coverage of research that focuses on the use of ultrasound to impact liver tumors, potentially affecting overall treatment outcomes.
For additional liver cancer coverage, click here.
Leading Breast Radiologists Discuss the USPSTF Breast Cancer Screening Recommendations
May 17th 2024In recognition of National Women’s Health Week, Dana Bonaminio, MD, Amy Patel, MD, and Stacy Smith-Foley, MD, shared their thoughts and perspectives on the recently updated breast cancer screening recommendations from the United States Preventive Services Task Force (USPSTF).
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
Current Insights and Emerging Roles for Contrast-Enhanced Mammography
May 10th 2024In a recent lecture at the 2024 ARRS Annual Meeting, Jordana Phillips, MD, discussed the role of contrast-enhanced mammography in staging breast cancer, evaluating response to neoadjuvant chemotherapy and recalls from screening.